2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument

Y. Xin, J. Lewsey, R. Gray, C.E. Clarke, E. McIntosh (Glasgow, United Kingdom)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Burden of movement disorders in Cameroon: In/out patient population study

J.N. Doumbe, Y. Mapoure, E. Cubo, T. Nyinyikua, K. Kompoliti (Douala, Cameroon)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Can a leopard changes its spots? How impulse control disorder affects subthalamic stimulation paradigm

N.G. Pozzi, B. Minafra, M. Picascia, R. Zangaglia, D. Servello, C. Pacchetti (Pavia, Italy)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Can deep brain stimulation implantation cause multiple system atrophy? A retrospective review of MSA patients

E.A. Coon, B.T. Klassen, J.E. Ahlskog, P.A. Low, W. Singer (Rochester, MN, USA)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Can intraoperative clinical testing really predict the effects of deep brain stimulation in the subthalamic nucleus?

J. Blume, J. Schlaier, F. Zeman, E. Rothenfußer, A. Brawanski, U. Bogdahn, M. Lange (Regensburg, Germany)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?

M.V. Alvarez, P.M. Grogan (San Antonio, TX, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Cancer comorbidity among PD patients; a population based large-scale cohort study

R. Gurel, N. Giladi, V. Rozani, T. Gurevich, B. El-Ad, B. Hemo, J. Tsamir, C. Peretz (Tel Aviv, Israel)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population

G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge de Saráchaga, M. Escobar-Barrios, E. Carreón-Bautista (Mexico City, Mexico)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Cardiovascular and cerebrovascular disorders are associated with a higher prevalence of parkinsonism: Data from a neuroepidemiologic community-based survey

S.M. Fereshtehnejad, M. Shafieisabet, A. Rahmani, A. Delbari, J. Lökk (Stockholm, Sweden)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2